The effect of low concentrations of lead on pre-and post-natal growth and development is a current concern. We describe a simple method of sample preparation for direct determination of lead in whole blood by Zeeman graphite-furnace atomic absorption spectrometry. This procedure improves analytical precision and accuracy of lead determinations at low concentrations as compared with published furnace data. At blood lead concentrations of 0.25, 1.98, and 3.76 pxnollL, within-run CVs were 3.2%, 1.8%, and 1.4% respectively; between-run CVs were 7.3%, 2.9%, and 2.2%. Accuracy, as demonstrated by analytical recovery, ranged from 99% to 102%. Our reproducibility/accuracy score in the 1989 Quebec interlaboratory comparison program was 96% compared with the target, second best of 66 participating laboratories. We compared various blood dilutions and sample volumes for optimal analytical sensitivity and accuracy. Both Triton dilutions and "protein-free" supernates were tested, with and without additionof inorganic lead,by direct aqueous calibrationas well as by standards addition. We adopted the followingprocedure,which yieldedthe best accuracy and analyticalprecisionwith both fresh blood and lyophilized control material: Thoroughly mix fresh or thawed whole blood on a rocker (we used an Adams Nutator, Model 1105; Clay Adams, Parsippany, NJ). Dilute the sample 10-foldby combining one volume ofblood (from a positive-displacement pipette)with four volumes of sample diluent(2.5 mL of Triton X-100 and 5 mL of Antifoam B per liter of ultrapure water) in an Eppendorf polypropylene micro test tube; then, after complete lysisof erythrocytes, add fivevolumes of 1.6molIL nitricacid.To thoroughly mix the sample, place the sample tube on the rocker while proceeding with the next sample.
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Recent publicationshave focused attention on the adverse effects of blood lead concentrationsas low as 0.48 mol/L (10.0 g/dL) on physicaland nervous system development in the pre-and post-natal period (1) (2) (3) (4) , as well as the influence of chroniclow lead exposure on cardiovascularfunctionin adults (3). Thus, preciseand accurate blood lead measurements are imperative at
thispotentialdecisionvalue. The refinement ofanalyticaltechniques over the past decade has increased accuracy in low-concentration blood lead measurement over that reported by Boone et al. (5) in 1979. In that study they compared interlaboratory resultsfrom the Centers forDisease Control (CDC) with resultsfrom a DefinitiveMethod (isotopedilution mass spectrometry).Among the various methods evaluated for lead quantification, graphite furnace atomic absorption spectrometry (GFAAS) did not rank highly in the relativeaccuracy and precisionratings.In general, at that time, all methods showed a positive bias at low lead concentrations and negative bias at abnormally high values. The overestimation (bias We compared various blood dilutions and sample volumes for optimal analytical sensitivity and accuracy. Both Triton dilutions and "protein-free" supernates were tested, with and without additionof inorganic lead,by direct aqueous calibrationas well as by standards addition. We adopted the followingprocedure,which yieldedthe best accuracy and analyticalprecisionwith both fresh blood and lyophilized control material: Thoroughly mix fresh or thawed whole blood on a rocker (we used an Adams Nutator, Model 1105; Clay Adams, Parsippany, NJ). Dilute the sample 10-foldby combining one volume ofblood (from a positive-displacement pipette)with four volumes of sample diluent(2.5 mL of Triton X-100 and 5 mL of Antifoam B per liter of ultrapure water) in an Eppendorf polypropylene micro test tube; then, after complete lysisof erythrocytes, add fivevolumes of 1.6molIL nitricacid.To thoroughly mix the sample, place the sample tube on the rocker while proceeding with the next sample. Pb, pmol/L (Table 3) .Recoveries were excellent(99-101%) over a range of analyticalvalues (0.35-2.40molIL).
Linearity
We examined the sensitivity of our analysisof fresh blood and reconstitutedcontrolsfrom two perspectives: 
Contamination Monitoring and Sample Collection
We monitored blood collection and sample processing equipment, including Vacutainer Tubes, Microtainer Tubes, syringes,Eppendorf tubes,and transferpipettes for minimum and maximum contamination with lead by overnight soaking with ultrapure water and 0.8 
Precision and Accuracy
Data are presented in Table 4 for within-run and between-run precisionof analysis,determined with Seronorm Whole Blood controls.
Analytical recovery data (Tables 2 and 3) show that our results compared very favorably with the target values established for both external quality-control programs. Our reproducibility/accuracy score in the 1989 performance summary of the Quebec Toxicology program was 96% compared with the target value, ranking us second of the 66 laboratories participating in lead analysis. Table 5 presents the results of the recent returns from the Quebec and CDC programs.
Reference Intervals
Using the described procedure, we determined the whole-blood lead concentration from 27 healthy, asymptomatic adults, 18 women and nine men. Mean results were 0.18 (SD 0.076) moIJL (3.7 ± 1.57 j.ig/dL) for the women and 0.23 (SD 0.086) moI/L (4.8 ± 1.78 g/dL) for the men. For the entire group, the mean blood lead 
DIscussIon
The effect of sample preparation on blood lead quantification by various methods has been recognized for some time (12) . In lead determination by GFAAS, various conditions affect analytical sensitivity and accuracy. Previous studies have examined some of these conditions, including sample digestion (13), simple sample dilution (6) (7) (8) (14) (15) (16) (17) , use of matrix modifiers (8, (15) (16) (17) , and directaqueous calibration (6, 16) or standards addition (7, 13, 14) in human or bovine blood. Accuracy and precision data have not always been presented. Delves (18) considered itunlikelythat direct calibration procedurescouldbe used forroutineanalysis of blood lead because accurate quantificationrequires some matching of the standard matrix with the sample.
The problems associatedwith directanalysisof whole blood by GFAAS includeimprecisedispensingof whole blood,effect ofmatrix on analyte sensitivity, incomplete recovery,poor precision, excessiveaccumulation ofcarbonaceous residues in the furnace (leading to decreased precision and suppression of the analyte signal, thereby Only one additionalpipettingstep is required in the sample preparation. Reagent blanks monitor possible contamination with lead. Carbon residues do not accumulate in the furnace, so we can generate as many as 300 firings before changing the graphite tube.
Calibration with Zeeman background correction GFAAS deviates from linearity at a lower absorbance than does deuterium background correctionbecause of the anomalous splitting patterns for most elements in a magnetic field. In the standards additionmode of calibration, this phenomenon reduces Zeeman analytical sensitivity. The ability to accurately quantifr lead by direct calibration as described is a distinct advantage in terms of analytical simplicity and sensitivity.
Analytical recovery experiments and control program performance confirm that this method of sample preparation and calibration produces accurate and precise data. Reconstituted lyophilized whole-blood controls and fresh blood performed equally well. Simple Tritondiluted blood samples did not compare well; fresh blood results were better than lyophilized controls, whether calibrated directly or by standards addition. Suppression of analyte signal,compared with that for a pure standard, was noted only when total sample dilution was less than fivefold. The ability to analyze a range of volumes of sample supernates without compromising accuracy makes this procedure very flexible in terms of analytical sensitivity.
Lead analysis of capillary blood samples reportedly has a positive bias due to contamination (16, 19) . As evidenced by our comparison of venous and capillary blood, and sequential capillary sampling, contamination is not a problem as long as a reasonably careful collection protocol is used.
We agree with Delves (18) that matrix suppression of the analyte signal, for a simple 10-fold Triton dilution of blood, warrants matrix matching of the standard curve. The fact that lyophilized controls yielded poorer recoveries than fresh blood against direct calibration is not surprising because of changes in the matrix. Although standards addition improved recoveries with lyophilized controls, recoveries were still low when compared with those for our method of sample preparation with direct calibration. Our method produces sensitive, accurate, and precise analytical data for venous or capillary blood samples.
The data obtained from 172 two-to three-year-old Vancouver children (11) reflect a geometric mean onehalf that reported in a 1988 survey of urban Ontario school children, ages six years and younger (20) . We contend that despite improvements in lead analysis, there is still a critical need for greater analytical accuracy and precision at lead values 0.48 mol/L (10.0 pg/dL). Only then can meaningful clinical information be gathered on the effects of low-concentration lead in the developing child.
